Correlation Between Aerovate Therapeutics and SOUTHERN

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Aerovate Therapeutics and SOUTHERN at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Aerovate Therapeutics and SOUTHERN into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Aerovate Therapeutics and SOUTHERN CALIF EDISON, you can compare the effects of market volatilities on Aerovate Therapeutics and SOUTHERN and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Aerovate Therapeutics with a short position of SOUTHERN. Check out your portfolio center. Please also check ongoing floating volatility patterns of Aerovate Therapeutics and SOUTHERN.

Diversification Opportunities for Aerovate Therapeutics and SOUTHERN

-0.71
  Correlation Coefficient

Pay attention - limited upside

The 3 months correlation between Aerovate and SOUTHERN is -0.71. Overlapping area represents the amount of risk that can be diversified away by holding Aerovate Therapeutics and SOUTHERN CALIF EDISON in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on SOUTHERN CALIF EDISON and Aerovate Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Aerovate Therapeutics are associated (or correlated) with SOUTHERN. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of SOUTHERN CALIF EDISON has no effect on the direction of Aerovate Therapeutics i.e., Aerovate Therapeutics and SOUTHERN go up and down completely randomly.

Pair Corralation between Aerovate Therapeutics and SOUTHERN

Given the investment horizon of 90 days Aerovate Therapeutics is expected to under-perform the SOUTHERN. But the stock apears to be less risky and, when comparing its historical volatility, Aerovate Therapeutics is 8.64 times less risky than SOUTHERN. The stock trades about 0.0 of its potential returns per unit of risk. The SOUTHERN CALIF EDISON is currently generating about 0.05 of returns per unit of risk over similar time horizon. If you would invest  8,624  in SOUTHERN CALIF EDISON on September 12, 2024 and sell it today you would earn a total of  340.00  from holding SOUTHERN CALIF EDISON or generate 3.94% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthWeak
Accuracy73.33%
ValuesDaily Returns

Aerovate Therapeutics  vs.  SOUTHERN CALIF EDISON

 Performance 
       Timeline  
Aerovate Therapeutics 

Risk-Adjusted Performance

12 of 100

 
Weak
 
Strong
Good
Compared to the overall equity markets, risk-adjusted returns on investments in Aerovate Therapeutics are ranked lower than 12 (%) of all global equities and portfolios over the last 90 days. In spite of rather fragile basic indicators, Aerovate Therapeutics exhibited solid returns over the last few months and may actually be approaching a breakup point.
SOUTHERN CALIF EDISON 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days SOUTHERN CALIF EDISON has generated negative risk-adjusted returns adding no value to investors with long positions. Despite somewhat strong basic indicators, SOUTHERN is not utilizing all of its potentials. The recent stock price disturbance, may contribute to short-term losses for the investors.

Aerovate Therapeutics and SOUTHERN Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Aerovate Therapeutics and SOUTHERN

The main advantage of trading using opposite Aerovate Therapeutics and SOUTHERN positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Aerovate Therapeutics position performs unexpectedly, SOUTHERN can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in SOUTHERN will offset losses from the drop in SOUTHERN's long position.
The idea behind Aerovate Therapeutics and SOUTHERN CALIF EDISON pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Competition Analyzer module to analyze and compare many basic indicators for a group of related or unrelated entities.

Other Complementary Tools

Portfolio Comparator
Compare the composition, asset allocations and performance of any two portfolios in your account
Insider Screener
Find insiders across different sectors to evaluate their impact on performance
ETFs
Find actively traded Exchange Traded Funds (ETF) from around the world
Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites